-
Long-Acting Regimen Shows Sustained HIV Control in Seniors
11 Nov 2025 09:39 GMT
… healthcare institutions in Spain.
They included 3146 people with HIV … TAKEAWAY:
The rates of HIV virologic suppression remained high … 21, 2025, in HIV Medicine.
LIMITATIONS:
The … receiving lecture fees from ViiV Healthcare, Janssen Pharmaceuticals, and…
-
Tamar Braxton Talks About HIV
11 Nov 2025 01:58 GMT
… was presented by the HIV pharmaceutical company ViiV Healthcare. In addition to educating … about the disproportionate impact of HIV … panelist Alftan Dyson, PharmD, of ViiV. “These are the lived realities …
-
Injectable PrEP approved in Northern Ireland following NHS milestone in monumental HIV breakthrough
10 Nov 2025 14:05 GMT
… the fight to combat HIV/AIDS.
The new long … to prevent sexually acquired HIV-1 infection.
Read next … efforts to reduce HIV incidence” – Julie Guest, ViiV Healthcare UK on the … ViiV Healthcare UK, highlighted the drug’s benefits: “Expanding the range of HIV …
-
ViiV Healthcare receives NICE recommendation for HIV prevention therapy
22 Oct 2025 12:29 GMT
… by GSK and Pfizer, with Shionogi joining as a shareholder in 2024, ViiV Healthcare … focuses on developing innovative treatments for HIV and AIDS. The … long-acting formulation of Apretude is manufactured at GSK …
-
Two-Drug Regimen Matches Three-Drug Regimen in HIV Care
04 Nov 2025 09:35 GMT
… treatment-naive people with HIV infection, the two-drug … treatment-naive people with HIV infection.
They enrolled 66 … groups, with total defective HIV-1 DNA showing comparable … This study received support from ViiV Healthcare. Additional funding came from …
-
Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment
20 Oct 2025 20:47 GMT
… The Global Fund to Fight AIDS, Tuberculosis and Malaria (the … GSK) and ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer … 70 million people from AIDS, TB and malaria since … and solidarity to end AIDS, TB and malaria, …
-
Huge disparities in PrEP uptake across Europe – injectable PrEP largely inaccessible
17 Nov 2025 12:50 GMT
… knew that it involves an HIV-negative person taking pills … always because their need for HIV prevention has changed. The meeting … 6% did not use any HIV prevention strategy after stopping … he had heard informally from ViiV Healthcare that only around 14,000 …
-
UK’s drug-cost watchdog recommends use of GSK unit’s HIV prevention drug
16 Oct 2025 23:10 GMT
… a positive recommendation for ViiV Healthcare’s HIV drug, enabling access to … in England and Wales, the GSK unit said on Friday.
… approved ViiV’s injection, Apretude, last year for prevention of HIV- … given every six months. GSK is exploring a long acting …
-
Fortrea Appoints Agnieszka Gallagher as General Counsel
17 Nov 2025 12:00 GMT
… and compliance at ViiV Healthcare, GSK Biologics, Sandoz International, Medtronic and Pfizer. Gallagher began … and diagnostic companies to drive healthcare innovation that accelerates life changing …
-
<![CDATA[Clinical Takeaways From ViiV’s PASO DOBLE and CLARITY Studies ]]>
29 Oct 2025 02:13 GMT
… HIV therapy as well as prevention,” he said.
References
1.ViiV Healthcare … HIV-1-with-significantly-less-weight-gain
2. ViiV Healthcare … . Press release. ViiV Healthcare. October 15, 2025 … gsk.com/en-gb/media/press-releases/viiv-healthcare …
About
© 1995-2025